Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea.

MLA

Katsumata, Yusuke, et al. “Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea.” Diagnostics (2075-4418), vol. 10, no. 2, Feb. 2020, p. 71. EBSCOhost, https://doi.org/10.3390/diagnostics10020071.

APA

Katsumata, Y., Terada, J., Matsumura, T., Koshikawa, K., Sakao, S., Tomiyoshi, G., Shinmen, N., Nakamura, R., Kuroda, H., Nagashima, K., Kobayashi, Y., Kobayashi, E., Iwadate, Y., Zhang, X.-M., Hiwasa, T., & Tatsumi, K. (2020). Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea. Diagnostics (2075-4418), 10(2), 71. https://doi.org/10.3390/diagnostics10020071

Chicago

Katsumata, Yusuke, Jiro Terada, Takuma Matsumura, Ken Koshikawa, Seiichiro Sakao, Go Tomiyoshi, Natsuko Shinmen, et al. 2020. “Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea.” Diagnostics (2075-4418) 10 (2): 71. doi:10.3390/diagnostics10020071.